Cost-benefit evaluation of anti-influenza vaccination in the elderly during two influenza seasons in the Siena district;Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella provincia di Siena

PharmacoEconomics - Italian Research Articles

Volumn 5, Issue SUPPL. 1, 2003, Pages 31-38

  Montomoli, Emanuele ^a   Pozzi, T ^a   Alfonsi, V ^a   Ghezzi, B ^a   Pilia, B ^a   Ravasio, R ^b   Lucioni, C ^b   Gasparini, R ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b Adis International Ltd   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; AMBROXOL; AMOXICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; ANTIVIRUS AGENT; CARBOCISTEINE; CEFONICID; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; CODEINE; DOXOFYLLINE; ERYTHROMYCIN; EXPECTORANT AGENT; INFLUENZA VACCINE; LEVDROPROPIZINE; MACROLIDE; MUCOLYTIC AGENT; NIMESULIDE; NORAMIDOPYRINE; PARACETAMOL; ROXITHROMYCIN; SEDATIVE AGENT; UNINDEXED DRUG;

AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; ECONOMIC EVALUATION; EPIDEMIC; EPIDEMIOLOGICAL DATA; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH STATUS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA; ITALY; POPULATION RESEARCH; QUESTIONNAIRE; SEASONAL VARIATION;

EID: 0038705308     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03320613     Document Type: Article

References (18)

1. Perez-Tirse J, Gross PA. Review of cost-benefit analysis of influenza vaccine. PharmacoEconomics 1992; 2 (3): 198-206
2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47 (R6):1-26
3. Postma MJ, Baltussen RM, Heynen ML, et al. Pharmacoeconomics of influenza vaccination in the elderly Drugs & Aging 2000; 17 (3): 217-27
4. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-52
5. Gasparini R, Pozzi T, Bonanni P, et al. Valutazione dei costi di un'epidemia influenzale nella popolazione lavorativa di Siena, Giornale di Farmacoeconomia 2000; 4: 3-9
6. Sullivan KM. Health impact of influenza in the United States. PharmacoEconomics 1996; 9 (suppl. 3): 26-33
7. Levy E. French economic evaluations of influenza and influenza vaccination. PharmacoEconomics 1996; 9 (suppl. 3): 62-6
8. McBean AM, Babish D, Warren JL. The impact and cost of influenza in the elderly. Ann Intern Med 1993; 153 (18): 2105-11
9. Monto SA. Individual and community impact of influenza. PharmacoEconomics 1999; 16 (suppl. 1): 1-6
10. Nichol KL, Goodman M. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. PharmacoEconomics 1999; 16 (suppl. 1): 63-71
11. INFLUCIRI. Centro interuniversitario di Ricerca sull'influenza: http://www.cirinet.it
12. Ministero della Salute: http://www.influnet.it
13. Istituto Superiore di Sanità. FLU-ISS. Sistema di sorveglianza sentinella dell'influenza basata su medici di medicina generale e pediatri di libera scelta. Rapporti ISTISAN 01/14
14. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123 (7): 518-27
15. Postma MJ, Bos JM, van Gennep M, et al. Economic evaluation of influenza vaccination: assessment for the Netherlands. PharmacoEconomics 1999; 16 (suppl. 1): 33-40
16. Scott WG, Scott HM. Economic evaluation of vaccination against influenza in New Zealand. PharmacoEconomics 1996; 9 (1): 51-60
17. Hak E, van Essen GA, Buskens E, et al. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice-based clinical prospective cohort study in Utrecht, the Netherlands. J Epidemiol Commun Health 1998; 52: 120-5
18. Nichol KL, Wuorenma RN, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769-76